Single dose radiation for early-stage or limited lung tumors
Part of Cancer, Lungs & breathing clinical trials.
This trial tests how a single, high-dose radiation treatment (called SBRT) affects quality of life and outcomes for people with certain lung tumors. It's for adults with early-stage non-small cell lung cancer or a lung tumor that has spread from another cancer, as long as the tumor is small and in the outer part of the lung.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have a lung tumor that is either early-stage non-small cell lung cancer or a lung tumor that has spread from another cancer (3 or fewer spots in the lung).
- The tumor is 3 cm or smaller, located in the outer part of the lung (not near the main airways or chest wall).
- You are scheduled to receive a single, high-dose radiation treatment (called SBRT) to the lung tumor.
- You have not had chemotherapy or other cancer treatments for this tumor, and you have not had radiation to the same area before.
- You are generally able to care for yourself (ECOG performance status 0-2) and are willing to follow the study schedule.
- You are covered by French health insurance and can give written informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a single, high-precision dose of radiation to the tumor instead of standard surgery or multiple radiation sessions. It is for women with a small, low-risk breast cancer who cannot or choose not to have surgery.
This trial studies a precise, high-dose radiation technique (SBRT) to treat tumors in the lungs. It may help control cancer in people who either have early-stage lung cancer that is not fully operable or have limited lung metastases from other cancers.
This trial tests a personalized radiation treatment called SBRT for early-stage non-small cell lung cancer that is located in the outer part of the lung and cannot be removed with surgery. The goal is to see if this approach works well for people who cannot have surgery or choose not to.
This study tests whether a single, very high-dose focused radiation treatment can control early-stage lung cancer. It may help people who can’t or prefer not to have surgery, by delivering precise radiation to the tumor while aiming to spare nearby tissue.
This trial tests whether a special type of focused radiation therapy can effectively treat advanced non-small cell lung cancer (the most common type) as an upfront treatment. It may help patients avoid or delay chemotherapy while controlling their cancer.
This trial tests a more precise radiation technique (stereotactic body radiotherapy) for early-stage lung cancer or small lung tumors. It aims to reduce side effects by eliminating the usual safety margin around the tumor.
Hear when a new SBRT trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.